Clinical Trials Directory

Trials / Completed

CompletedNCT03716700

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Status
Completed
Phase
—
Study type
Observational
Enrollment
126 (actual)
Sponsor
Baxalta now part of Shire · Industry
Sex
All
Age
3 Years
Healthy volunteers
Not accepted

Summary

This study will provide insights on the infusion parameters, dosing, and experience of participants transitioning to CUVITRU in a real-world setting.

Conditions

Interventions

TypeNameDescription
BIOLOGICALCUVITRUCUVITRU

Timeline

Start date
2018-09-24
Primary completion
2020-07-23
Completion
2020-07-23
First posted
2018-10-23
Last updated
2021-03-05

Locations

3 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT03716700. Inclusion in this directory is not an endorsement.

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN) (NCT03716700) · Clinical Trials Directory